EmitBio Treatment Broadly Effective Against Coronavirus Variants

An important weapon in the global fight against an enemy that keeps evolving

Durham, N.C. (March 10, 2021) – EmitBio Inc., today announced new evidence that demonstrates its proprietary light technology can inactivate variants of the coronavirus that causes COVID-19, including the highly infectious United Kingdom and South Africa variants. These findings indicate important effectiveness against potentially more transmissible mutations of COVID-19.